LRI Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.5K Buy
186
+2
+1% +$923 0.01% 447
2026
Q1
$88.4K Hold
184
0.01% 428
2025
Q4
$103K Hold
184
0.01% 410
2025
Q3
$94.6K Hold
184
0.01% 429
2025
Q2
$57.8K Hold
184
﹤0.01% 527
2025
Q1
$56.1K Hold
184
0.01% 522
2024
Q4
$61.1K Hold
184
0.01% 501
2024
Q3
$61.6K Hold
184
0.01% 488
2024
Q2
$75.8K Hold
184
0.01% 429
2024
Q1
$74.4K Buy
+184
New +$64.7K 0.02% 237

Other funds holding MEDP

LRI Investments's MEDP Position: Q2 2026 in Review

LRI Investments increased its Medpace (MEDP) stake by 1.1% in Q2 2026, buying an estimated $923 and bringing the position to 186 shares worth $98.5K. The position accounts for 0.01% of the portfolio, ranked #447.

LRI Investments first reported a position in MEDP in Q1 2024 and has held it in 10 quarters since. The position peaked at $103K in Q4 2025. 234 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • LRI Investments held 186 shares of Medpace worth $98.5K as of Q2 2026.
  • LRI Investments bought 2 Medpace shares in Q2 2026, an estimated $923.
  • Medpace made up 0.01% of LRI Investments's portfolio in Q2 2026, its #447 holding.
  • LRI Investments first reported a position in Medpace in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Medpace position peaked at $103K in Q4 2025.
  • 234 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.